Onur Çelik is the President of Leafwell, one of the nation's leading medical cannabis telehealth companies, operating across 38 states and serving approximately 200,000 patients annually. Leafwell is focused on expanding access to medical cannabis, integrating cannabis into mainstream healthcare, and helping establish the clinical evidence and infrastructure needed to support broader adoption and reimbursement.

Onur brings extensive experience in strategy, growth, and M&A across healthcare and consumer industries. He began his career at McKinsey & Company, where he was an Associate Partner, and subsequently served as Chief Strategy Officer and Head of Product at Fontem Ventures, helping drive product development and the international expansion of its blu vaping business.